New Market Report: Vietnam Pharmaceuticals & Healthcare Report Q4 2013
The government's promise to improve healthcare conditions through rising expenditure will bring potential growth to pharmaceutical firms over the longer term. However, we highlight that there may be a risk of not fulfilling such aims, given extensive bureaucracy and rampant corruption. In addition, the macroeconomic condition was less -than optimistic between Q1 and Q2 this year. Should this continue, it will be challenging for the country to invest in healthcare substantially.
View full press release